• 6371 Citations
  • 41 h-Index
1978 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where J. Szebeni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Complement Activation Medicine & Life Sciences
Liposomes Medicine & Life Sciences
Chemical activation Chemical Compounds
Hypersensitivity Medicine & Life Sciences
Swine Medicine & Life Sciences
Nanomedicine Medicine & Life Sciences
complement Physics & Astronomy
Hemoglobins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

4 Citations (Scopus)

Acute physiological changes caused by complement activators and amphotericin b-containing liposomes in mice

Őrfi, E., Mészáros, T., Hennies, M., Fülöp, T., Dézsi, L., Nardocci, A., Rosivall, L., Hamar, P., Neun, B. W., Dobrovolskaia, M. A., Szebeni, J. & Szénási, G., Jan 1 2019, In : International journal of nanomedicine. 14, p. 1563-1573 11 p.

Research output: Contribution to journalArticle

Open Access
Amphotericin B
Chemical activation
Open Access
Complement Activation

Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs

Bavli, Y., Winkler, I., Chen, B. M., Roffler, S., Cohen, R., Szebeni, J. & Barenholz, Y., Jul 28 2019, In : Journal of Controlled Release. 306, p. 138-148 11 p.

Research output: Contribution to journalArticle

liposomal doxorubicin